Strs Ohio C4 Therapeutics, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	$3.1 - $9.02 $17,360 - $50,512	5,600 New	5,600 $17,000
Q2 2021 Jul 26, 2021	SELL	$30.39 - $42.18 $264,393 - $366,966	-8,700 Reduced 60.84%	5,600 $211,000
Q1 2021 Apr 23, 2021	BUY	$31.96 - $46.5 $373,932 - $544,050	11,700 Added 450.0%	14,300 $528,000
Q4 2020 Jan 25, 2021	BUY	$22.8 - $37.05 $59,280 - $96,329	2,600 New	2,600 $86,000

124

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $179M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.